Showing 141-150 of 4078 results for "".
Finding the Perfect Sunscreen for Patients with Skin of Color
https://practicaldermatology.com/columns/skin-cancer-essentials/finding-the-perfect-sunscreen-for-patients-with-skin-of-color/56391/There are a few existing resources that have reviewed and rated sunscreen products and their components;5 few are in scientific journals, and many are short magazine review articles with only a few selections discussed. A team of experts provides comprehensive resource on sunscreens compatible withVitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Update On the Use of Spironolactone to Treat Adult Female Acne
https://practicaldermatology.com/topics/general-topics/update-on-the-use-of-spironolactone-to-treat-adult-female-acne/20917/There is a role for spironolactone in some adult female acne patients.Bimekizumab-bkzx Journal Scan: 4 Clinical Trials
https://practicaldermatology.com/topics/digital-supplement/bimekizumab-bkzx-journal-scan-4-clinical-trials/24128/Speed, depth, and durability from the first dual IL-17A/F inhibitor for the treatment of moderate to severe plaque psoriasis.Technology Solutions: Q&A With Nextech's Dr. Jason Handza
https://practicaldermatology.com/topics/practice-management/technology-solutions-q-nextechs-dr-jason-handza/28649/Nextech this year introduced Nextech RCM Professional Billing Services, an addition to their practice management software suite. This solution simplifies insurance billing complexities, helping practices reduce administrative burdens and enhance financial performance through optimized cash flow.The Excoriated and Bleeding Edge: Updates in Eczema for the Clinician
https://practicaldermatology.com/topics/general-topics/the-excoriated-and-bleeding-edge-updates-in-eczema-for-the-clinician/21469/Atopic dermatitis continues to present treatment challenges, but a steady juggling of four main components—moisturization, antibiotics, anti-inflammatory, and antipruritics— help to maximize control of the disease.Lose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Inflammatory Responses: Managing Psoriasis in Light of Comorbidities
https://practicaldermatology.com/topics/psoriasis/inflammatory-responses-managing-psoriasis-in-light-of-comorbidities/20440/The accumulated evidence suggests that dermatologists must take an active role in addressing risks.Jejunal Trichobezoar in a 3-year-old Boy; Practice Path MD Pro Tip: Architects
https://practicaldermatology.com/youngmd-connect/resident-resource-center/jejunal-trichobezoar-in-a-3-year-old-boy-practice-path-md-pro-tip-architects/20697/